MyCural Therapeutics
- Biotech or pharma, therapeutic R&D
MyCural Therapeutics is a Swedish biotech company developing a novel small molecule therapy targeting the MYC oncoprotein—one of the most elusive and prevalent drivers of cancer. Built on 15 years of academic research and scientific expertise, we are now seeking strategic partners and investors to advance this promising approach toward clinical development.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}